Correspondence on Editorial regarding “Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations”
Clinical and Molecular Hepatology. 2023;29(1):185-187 
Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations
Clinical and Molecular Hepatology. 2022;28(4):802-805
Tumor necrosis factor and its potential role in insulin resistance and nonalcoholic fatty liver disease
Clinics in Liver Disease. 2004;8(3):619-638
Insulin resistance in nonalcoholic fatty liver disease
Atherosclerosis Supplements. 2002;3(2):79
Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments
Nutrients. 2017;9(4):387
Diagnostic accuracy of adipose insulin resistance index and visceral adiposity index for progressive liver histology and cardiovascular risk in nonalcoholic fatty liver disease
Hepatology. 2012;56(2):788-789
Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease
Clinics in Liver Disease. 2004;8(3):575-594
Insulin Therapy and Autoimmune Disease with Relevance to Non Alchoholic Fatty Liver Disease
Nonalcoholic Fatty Liver Disease - An Update. 2019;
Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients
Nutrition Research. 2014;34(2):143-148
Risk of severe liver disease in nonalcoholic fatty liver disease: Role of insulin resistance
Hepatology. 2008;48(6):2088-2088